1. Home
  2. BAH vs GKOS Comparison

BAH vs GKOS Comparison

Compare BAH & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Booz Allen Hamilton Holding Corporation

BAH

Booz Allen Hamilton Holding Corporation

N/A

Current Price

$88.60

Market Cap

9.3B

ML Signal

N/A

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$239.97

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAH
GKOS
Founded
1914
1998
Country
United States
United States
Employees
31500
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
9.7B
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
BAH
GKOS
Price
$88.60
$239.97
Analyst Decision
Hold
Strong Buy
Analyst Count
15
13
Target Price
$89.00
★ $234.00
AVG Volume (30 Days)
★ 1.8M
1.2M
Earning Date
10-23-2026
10-28-2026
Dividend Yield
★ 2.80%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.13
N/A
Revenue
★ $11,217,000,000.00
$507,442,000.00
Revenue This Year
$1.37
$53.82
Revenue Next Year
$4.61
$28.70
P/E Ratio
$26.83
★ N/A
Revenue Growth
N/A
★ 32.33
52 Week Low
$59.50
$80.91
52 Week High
$109.10
$243.71

Technical Indicators

Market Signals
Indicator
BAH
GKOS
Relative Strength Index (RSI) 79.07 85.03
Support Level $74.35 $147.72
Resistance Level $90.54 N/A
Average True Range (ATR) 3.01 8.77
MACD 1.48 7.47
Stochastic Oscillator 91.54 90.15

Price Performance

Historical Comparison
BAH
GKOS

About BAH Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace. The domains includes Consulting Services- Delivering strategic, operational, and management consulting to transform organizations; Advanced Tech- artificial intelligence, cloud integration, and data platforms. Cybersecurity that protects critical national infrastructure, military networks, and sensitive government systems and Engineering Solutions providing mission-critical technical design and hardware integration.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: